The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,773.50
Bid: 1,772.00
Ask: 1,772.50
Change: 12.50 (0.71%)
Spread: 0.50 (0.028%)
Open: 1,770.00
High: 1,776.00
Low: 1,766.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Roche says US allows it to tap adult Tamiflu reserves

Thu, 17th Jan 2013 22:45

* Roche says extra Tamiflu supplies will have differentpackaging

* Says spot shortages of children's liquid Tamiflu tocontinue

* Safeway, Rite Aid ship additional vaccine to U.S. stores

By Ransdell Pierson

Jan 17 (Reuters) - Roche Holding AG said U.S.regulators will allow it to begin selling the company's reservestock of adult Tamiflu capsules, and that the extra supplies ofthe flu treatment should meet U.S. demand for that formulationfor the rest of this flu season.

The Swiss drugmaker said the U.S. Food and DrugAdministration will allow it to sell Tamiflu capsules indifferent packaging from what is currently available in theUnited States.

"The medicine from our reserve stock is the same as themedicine that is currently being distributed," and in the same75 milligram adult dose, said company spokeswoman TaraIannuccillo.

But Roche's Genentech unit, which makes Tamiflu, said itcontinues to expect spot shortages of a different liquidformulation used by children because continuing production of itwill not meet demand.

The company said pharmacists can create a substitute liquidformulation by dissolving Tamiflu capsules into a sweet liquid.

Tamiflu is used to slow down or stop symptoms of the flu inpeople that already have been infected with the virus.

Shortages of the treatment come as the United States isexperiencing one of the worst influenza epidemics of the pastdecade.

Health officials have said it is not too late for people tobe vaccinated, but many across the country have had difficultyfinding available vaccines at doctors' offices and drugstores.

Sanofi SA, the largest flu vaccine provider in theUnited States, last week said it had sold out of four of the sixformulations of its Fluzone seasonal flu vaccine due to theunanticipated late-season demand for vaccines.

Drugstore chain Rite Aid Corp on Thursday said ithad obtained more than 400,000 additional doses of seasonal flushots, which are being delivered to areas of need based onactual or anticipated flu outbreak. The vaccine will beadministered by pharmacists in its U.S. drugstores.

Safeway Inc on Wednesday said it had shipped anadditional 200,000 does of its vaccine to its U.S. pharmacies tomeet high demand. The supermarket chain offered customers whoreceive the vaccine a coupon for 10 percent off their nextgrocery purchase.

Forty-seven states are reporting widespread influenzaactivity, and the nation's capital is also battling the seasonalscourge, which can be spread to others up to six feet away whenpeople with flu cough, sneeze or talk.

Dozens of hand sanitizers cropped up this week at the U.S.Capitol in Washington, amidst heated preparations, and intensesecurity, for President Barack Obama's second inauguration onMonday.

With hundreds of thousands of people expected to jam thecity - particularly at crowded inaugural balls - healthofficials warned those who attend to wash their hands regularlyand consider bringing hand sanitizer. And they had advice bothfor those who are ill - Stay home - and for those who are not:Get vaccinated, if you have not already done so.

More News
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.